December 18, 2014 2:46 AM ET

Professional Services

Company Overview of Ability Biomedical Corp.

Executive Profile

Hans S. Keirstead Ph.D.

President of NeoStem Oncology, Neostem, Inc.
AgeTotal Calculated CompensationThis person is connected to 5 Board Members in 5 different organizations across 7 different industries.

See Board Relationships
----

Background

Dr. Hans S. Keirstead, PhD serves as the President of NeoStem Oncology at Neostem, Inc. Dr. Keirstead serves as Chief Executive Officer and President at California Stem Cell, Inc. Dr. Keirstead founded Ability Biomedical Corporation and serves as its President and Chief Executive Officer. Dr. Keirstead served as Chief Executive Officer of Neuron Therapeutics, Inc. since 2000 and was responsible for developing its IND application and clinical trials program. He maintains ...

Corporate Headquarters

1055 West Georgia Street
Vancouver, British Columbia V6E 3R5

Canada

Phone: 604-689-9912
Fax: 604-692-0295

Board Members Memberships

President, Chief Executive Officer, and Director
2014-Present
Director

Education

PhD
University Of British Columbia
Doctorate
University of Cambridge

Other Affiliations

Annual Compensation

There is no Annual Compensation data available.

Stocks Options

There is no Stock Options data available.

Total Compensation

There is no Total Compensation data available.
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup

COMPETITOR COMPENSATION

NamePosition/
Company
Compensation
Dominick C. Colangelo Esq.Chief Executive Officer, President, Treasurer and Director
Vericel Corporation
$358.3K
Gil Van Bokkelen Ph.D.Co-Founder, Chairman and Chief Executive Officer
Athersys, Inc.
$568.8K
Robin C. Stracey Interim Chief Executive Officer, Director, Chairman of Compensation Committee, Member of Audit Committee and Member of Governance & Nominating Committee
Cesca Therapeutics Inc.
--
Marc H. Hedrick M.D.Chief Executive Officer, President and Director
Cytori Therapeutics, Inc.
$406.6K
Martin P. Rosendale Chief Executive Officer and Director
Nuo Therapeutics, Inc.
$467.3K
Compensation as of Fiscal Year 2013.

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact Ability Biomedical Corp., please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.